IN Capital
约印医疗基金
elsewhere's corpus does not cover IN Capital as a distinct subject. The retrieved material contains only passing name-drops of "January Capital" (a different entity) as a co-investor in Southeast Asian deals alongside 5Y Capital, with no substantive information about its identity, founding, strategy, or team . No entity card or dedicated coverage exists for IN Capital in the bundle.
AI-generated — may contain errors, please verify.
IN CapitalFund
约印医疗基金
渲染中…
Mentioned in 3 articles
Coverage
ImmuPharm Raises Nearly RMB 200 Million in Pre-IPO Round Co-Led by Gaorong Ventures, Building Dual Engine in Solid Tumors and In Vivo CAR-T
Bringing long-term survival benefits to cancer patients worldwide.
Medical Device/Chip Companies Close New Funding Rounds, Driving High-Quality Growth Through R&D, Commercialization, and Supply Chain | Rong Report · February
Infinite possibilities for creating a better life.
Haijieya Completes New Funding Round to Build Integrated Platform for Interventional Oncology Treatment
Providing a comprehensive suite of minimally invasive interventional diagnosis and treatment solutions for oncology.
